Abstract
Background: Attention–Deficit/Hyperactivity Disorder (ADHD) is the most commonly diagnosed childhood psychiatric disorder. Children with ADHD have been found to have cognitive deficits, lower IQ, impaired social relationships with in the family and with peers as well as poor study skills and lower academic achievement. ADHD prevalence is estimated to be 5% for the Indian paediatric population. The persistence of these problems highlights the need for effective treatment. Objective: The main objective of the present study was to evaluate the comparative effect of Naladadi Ghrita with Kushmanda Ghrita in reducing the signs and symptoms of ADHD. Materials and Methods: A total of 20 subjects with ADHD satisfying the DSM‑IV TR diagnostic criteria were selected and divided in to two groups by following randomisation method. Trial group received Naladadi Ghrita 5 ml twice a day and control group received Kushmanda Ghrita 5 ml twice a day for 1 month. Two assessments were done before and after the treatment. Criterion of assessment was based on the scoring of ADHD Rating Scale. Paired and unpaired ‘t’‑test was used for statistical analysis. Results and Conclusion: Naladadi Ghrita and Kushmanda Ghrita both were effective on ADHD Rating Scale and they provided 35%, 38.68% of relief, respectively (P 0.05). Key words: ADHD rating scale, attention–deficit/hyperactivity disorder, Kushmanda ghrita, Naladadi ghrita
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.